Today, clinical trials are the bottleneck to bringing life-saving treatments to patients. Trials are slow, inefficient, and expensive. We believe that we can use technology to accelerate the pace of clinical trials and bridge the gap between medical research and patients who need treatment.
There are more than 7,000 known human diseases, but we have treatments for fewer than 500 of them. Despite sweeping technological changes transforming the world, it still takes more than 10 years and hundreds of millions of dollars to bring a new drug to market.
The bottleneck of getting new treatments to patients is the time it takes to run a clinical trial, not the ability to discover new drugs (which is actually becoming more efficient). We started TrialSpark with this vision: to decrease the time and cost of a clinical trial, so that every year we can test more life-impacting treatments for real human diseases, ultimately bringing them to patients faster.
At some point in our lives, we all become patients. We are all the beneficiaries of medical research pioneered by doctors and patients before us. At TrialSpark, we believe this is the most important problem in the world - one that is much bigger than our company.
Ben & Linhao
We’re a team of researchers, engineers, and designers dedicated to accelerating breakthroughs in medical research. We’re passionate about democratizing access to clinical trials and the newest drugs and therapies as soon as they become available.